share_log

圣诺生物(688117.SH):泊沙康唑注射液获得药品注册证书

Sennuo Biotech (688117.SH): Posaconazole injection obtained drug registration certificate

Gelonghui Finance ·  May 6 04:30

On May 6, GLONGHUI (688117.SH) announced that Chengdu Shengnuo Biopharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received a “Drug Registration Certificate” for posaconazole injections issued by the State Drug Administration. Posaconazole injection is a broad-spectrum antifungal drug whose main component is posaconazole. This drug is suitable for treating diseases caused by fungi, such as invasive aspergillosis, invasive myxomycosis, cryptococcosis, etc.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment